STING1 and neoplasm: Because radiotherapy can induce anti-tumor T cell responses by inducing type I IFN production in a cGAS-STING-dependent manner [121], cancer cells can develop resistance to radiotherapy through a loss of cGAS-STING signaling [5, 28, 58].